ABCC1 p.Asp1454Asn
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 15755910
[PubMed]
Payen L et al: "Functional interactions between nucleotide binding domains and leukotriene C4 binding sites of multidrug resistance protein 1 (ABCC1)."
No.
Sentence
Comment
67
The forward primers for the D792N and D1454N mutations of the Walker B motifs were 5Ј-CATTTACCTCT- TCAATGATCCCCTC-3Ј and 5Ј-ATCCTTGTGTTGAATGAGGCCA- CG-3Ј, respectively.
X
ABCC1 p.Asp1454Asn 15755910:67:38
status: NEW189 The D792N mutation diminished transport activity by approximately 65%, whereas the D1454N mutation essentially inactivated the protein (Fig. 5B).
X
ABCC1 p.Asp1454Asn 15755910:189:83
status: NEW191 In contrast, the D1454N mutation eliminated photolabeling of only NBD2 and had no effect on photolabeling of NBD1 (Fig. 5C).
X
ABCC1 p.Asp1454Asn 15755910:191:17
status: NEW192 The D792N mutation also strongly decreased ADP trapping by both NBD1 and NBD2, although the D1454N mutation eliminated trapping by NBD2 but only modestly decreased trapping by NBD1 (Fig. 6B).
X
ABCC1 p.Asp1454Asn 15755910:192:92
status: NEW228 The relative expression levels of wt and mutant half-molecules were evaluated by densitometry and are indicated on the figure. B, effect of D792N and D1454N mutations on ATP-dependent LTC4 transport activity.
X
ABCC1 p.Asp1454Asn 15755910:228:150
status: NEW229 Membrane vesicles (2 g) containing wt and the D792N and D1454N mutant MRP1 half-molecules or control beta-gus were assayed for ATP-dependent LTC4 transport activity by incubation in transport buffer containing [3 H]LTC4 (50 nM, 0.13 Ci) at 23°C for 2 min in the presence and absence of ATP (4 mM) as described under Materials and Methods. Results shown are means Ϯ S.D. of triplicate determinations in a single experiment.
X
ABCC1 p.Asp1454Asn 15755910:229:64
status: NEW230 Similar results were obtained in three additional independent experiments. C, effect of D792N and D1454N mutations on photolabeling with 8-azido-[␣-32 P]ATP.
X
ABCC1 p.Asp1454Asn 15755910:230:98
status: NEW242 The effect of the MRP1 Walker B D792N and D1454N mutations on ATP binding and ADP trapping was similar to that of the Walker A lysine mutations; the level of transport activity of the NBD1 aspartic acid-to-asparagine mutation was comparable with that of the Walker A lysine-to-methionine mutation (Gao et al., 2000).
X
ABCC1 p.Asp1454Asn 15755910:242:42
status: NEW258 Densitometry indicated that the level of the D1454N mutant protein in the vesicle preparation used was approximately 2-fold higher than in control vesicles (A).
X
ABCC1 p.Asp1454Asn 15755910:258:45
status: NEW260 B, effect of D792N and D1454N mutations on vanadate-dependent nucleotide trapping.
X
ABCC1 p.Asp1454Asn 15755910:260:23
status: NEW265 C, effect of D792N and D1454N mutations on LTC4 photolabeling in the presence or absence of nucleotide.
X
ABCC1 p.Asp1454Asn 15755910:265:23
status: NEW266 Membrane vesicles (50 g of total protein) containing wt and the D792N and D1454N mutant MRP1 half-molecules were incubated in transport buffer at 23°C for 20 min in the absence or presence of ATP␥S (4 mM) or ATP (1 mM) plus vanadate (1 mM) before the addition of [3 H]LTC4 (200 nM, 0.13 Ci).
X
ABCC1 p.Asp1454Asn 15755910:266:82
status: NEW
PMID: 17187755
[PubMed]
Yang R et al: "Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport."
No.
Sentence
Comment
189
For example, ATP binding to wild-type MRP1 can transport the bound LTC4 from high to low affinity site whereas ATP binding to the K684R- or the D1454N-mutated MRP1 cannot [30].
X
ABCC1 p.Asp1454Asn 17187755:189:144
status: NEW
PMID: 17295059
[PubMed]
Chang XB et al: "A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1."
No.
Sentence
Comment
241
Indeed, several mutations, such as K684E, K1333E, K684R, K1333R, D792N, D1454N, G771A and G1433A, significantly diminished ATP binding and Vi-dependent ADP trapping at NBD2 and lost the ability to shift the substrate binding from a high to low affinity site [61].
X
ABCC1 p.Asp1454Asn 17295059:241:72
status: NEW
PMID: 18088596
[PubMed]
Yang R et al: "The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function."
No.
Sentence
Comment
254
In order to rule out the possibility that the double mutant D1454L/E1455L might rescue the misfolding caused by D14 54L mutation, we have made single mutants including D1454L, D1454N, S1334A, S1334T, S1334C, S1334H, S1334D and S1334N.
X
ABCC1 p.Asp1454Asn 18088596:254:176
status: NEW261 It is also true for the corresponding mutations in Walker B motif of NBD2 in MRP1, such as D1454L (manuscript in preparation) and D1454N [46], have a significant effect on the ATP-dependent LTC4 transport.
X
ABCC1 p.Asp1454Asn 18088596:261:130
status: NEW
PMID: 19949927
[PubMed]
Chang XB et al: "Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1."
No.
Sentence
Comment
157
Indeed, several mutations, such as K684E, K1333E, K684R, K1333R, D792N, D1454N, G771A and G1433A, significantly diminished ATP binding and lost the ability to shift the bound substrate from high to low affinity site (99).
X
ABCC1 p.Asp1454Asn 19949927:157:72
status: NEW
PMID: 21799180
[PubMed]
Henderson MJ et al: "ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug Efflux."
No.
Sentence
Comment
66
For constitutive expression of ABCC1 in SH-SY5Y cells, transfection with pCMV14-3xFLAG-ABCC1, or the ATP-binding site mutants, pCMV14-3xFLAG-ABCC1-D1454N or ABCC1-DE1454LL, was followed by selection of stable clones with 500 µg/ml G418 (Geneticin; Invitrogen Australia Pty Ltd, Mulgrave, Australia), which were subsequently maintained with 150 µg/ml G418.
X
ABCC1 p.Asp1454Asn 21799180:66:147
status: NEW67 The ABCC1-D1454N mutation was previously shown to abolish ATP-dependent ABCC1 transporter activity while not affecting correct localization of the transporter (19), and the ABCC1-DE1454LL mutant was predicted to have similar properties (Supplementary Figure 1, available online and http://www.uniprot.org/uniprot/O15439; accessed June, 2010).
X
ABCC1 p.Asp1454Asn 21799180:67:10
status: NEWX
ABCC1 p.Asp1454Asn 21799180:67:147
status: NEW74 Generation of ATP-binding site mutants was carried out accordingtotheQuikChangeLightningSite-DirectedMutagenesis Kit (Stratagene, La Jolla, CA) using forward primer 5'-ATC CTT GTG TTG AAT GAG GCC ACG GCA G-3' for ABCC1-D1454N (single mutant), forward primer 5'-ATC CTT GTG TTG CTT CTG GCC ACG GCA G-3' for ABCC1-DE1454/1455LL (double mutant) and forward primer 5'-AGG TGG GGA TCT TCG GCC GCA CTG G-3' for ABCC3-V1322F.
X
ABCC1 p.Asp1454Asn 21799180:74:219
status: NEW151 ABCC1 transporter activity is necessary for the observed effects on cell motility, because forced expression of catalytically inactive ABCC1 (ABCC1-D1454N clone B4 or ABCC1-DE1454LL clone B7) had no impact on cell motility (mean % of wound open ± 95% CI: ABCC1 B4, 49.6 ± 4.5 vs empty vector, 59.9 ± 9.6, P = .08; ABCC1 B7, 55.6 ± 9.0 vs empty vector, 59.9 ± 9.6, P = .54, one-way ANOVA and two-sided t test, three independent Figure 2.Impact of ABCC1 and ABCC4 suppression in BE(2)-C human neuroblastoma cells.
X
ABCC1 p.Asp1454Asn 21799180:151:148
status: NEW163 This effect was completely abrogated in cells overexpressing the mutant ABCC1 carrying a single amino acid change in the ABC domain (D1454N) or the catalytically inactive double mutant of ABCC1 (DE1454LL) (mean number of colonies ± 95% CI: ABCC1 B4, 74.8 ± 1.6 vs empty vector, 73.9 ± 4.3, P = .96; ABCC1 B7, 73.5 ± 5.9 vs empty vector, 73.9 ± 4.3, P = .88; one-way ANOVA and two-sided t test, four independent experiments; Figure 3, D).
X
ABCC1 p.Asp1454Asn 21799180:163:133
status: NEW182 A) Western blot analysis of ABCC1 protein expression following stable transduction of SH-SY5Y cells with either empty vector, wild-type (wt) ABCC1 (clones D5, H7), ABCC1 D1454N single mutant (clone B4), or ABCC1 DD1454LL double mutant (clone B7) constructs.
X
ABCC1 p.Asp1454Asn 21799180:182:170
status: NEW68 The ABCC1-D1454N mutation was previously shown to abolish ATP-dependent ABCC1 transporter activity while not affecting correct localization of the transporter (19), and the ABCC1-DE1454LL mutant was predicted to have similar properties (Supplementary Figure 1, available online and http://www.uniprot.org/uniprot/O15439; accessed June, 2010).
X
ABCC1 p.Asp1454Asn 21799180:68:10
status: NEW75 Generation of ATP-binding site mutants was carried out accordingtotheQuikChangeLightningSite-DirectedMutagenesis Kit (Stratagene, La Jolla, CA) using forward primer 5'-ATC CTT GTG TTG AAT GAG GCC ACG GCA G-3' for ABCC1-D1454N (single mutant), forward primer 5'-ATC CTT GTG TTG CTT CTG GCC ACG GCA G-3' for ABCC1-DE1454/1455LL (double mutant) and forward primer 5'-AGG TGG GGA TCT TCG GCC GCA CTG G-3' for ABCC3-V1322F.
X
ABCC1 p.Asp1454Asn 21799180:75:219
status: NEW152 ABCC1 transporter activity is necessary for the observed effects on cell motility, because forced expression of catalytically inactive ABCC1 (ABCC1-D1454N clone B4 or ABCC1-DE1454LL clone B7) had no impact on cell motility (mean % of wound open ± 95% CI: ABCC1 B4, 49.6 ± 4.5 vs empty vector, 59.9 ± 9.6, P = .08; ABCC1 B7, 55.6 ± 9.0 vs empty vector, 59.9 ± 9.6, P = .54, one-way ANOVA and two-sided t test, three independent Figure 2.Impact of ABCC1 and ABCC4 suppression in BE(2)-C human neuroblastoma cells.
X
ABCC1 p.Asp1454Asn 21799180:152:148
status: NEW164 This effect was completely abrogated in cells overexpressing the mutant ABCC1 carrying a single amino acid change in the ABC domain (D1454N) or the catalytically inactive double mutant of ABCC1 (DE1454LL) (mean number of colonies ± 95% CI: ABCC1 B4, 74.8 ± 1.6 vs empty vector, 73.9 ± 4.3, P = .96; ABCC1 B7, 73.5 ± 5.9 vs empty vector, 73.9 ± 4.3, P = .88; one-way ANOVA and two-sided t test, four independent experiments; Figure 3, D).
X
ABCC1 p.Asp1454Asn 21799180:164:133
status: NEW183 A) Western blot analysis of ABCC1 protein expression following stable transduction of SH-SY5Y cells with either empty vector, wild-type (wt) ABCC1 (clones D5, H7), ABCC1 D1454N single mutant (clone B4), or ABCC1 DD1454LL double mutant (clone B7) constructs.
X
ABCC1 p.Asp1454Asn 21799180:183:170
status: NEW